-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LTvhd39C2bNaOvoQBTLOkH2fnBST17N8/J1XYAta09uvW5uO074kqK1HuA2Q2VRI eI0VBPNkSXCySl5P9//YcA== 0001209191-10-018088.txt : 20100319 0001209191-10-018088.hdr.sgml : 20100319 20100319215229 ACCESSION NUMBER: 0001209191-10-018088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100318 FILED AS OF DATE: 20100319 DATE AS OF CHANGE: 20100319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Raser Jeffrey CENTRAL INDEX KEY: 0001346901 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51665 FILM NUMBER: 10695399 MAIL ADDRESS: STREET 1: 12750 HIGH BLUFF DRIVE STREET 2: SUITE 310 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Somaxon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001339455 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200161599 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 210 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: (858) 480-0400 MAIL ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 210 CITY: SOLANA BEACH STATE: CA ZIP: 92075 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-03-18 0 0001339455 Somaxon Pharmaceuticals, Inc. SOMX 0001346901 Raser Jeffrey SOMAXON PHARMACEUTICALS, INC. 3830 VALLEY CENTRE DRIVE, SUITE 705-461 SAN DIEGO CA 92130 0 1 0 0 Senior VP, Sales and Marketing Common Stock 2010-03-18 4 S 0 7770 6.5581 D 19730 D Common Stock 2010-03-18 4 S 0 2400 7.8138 D 17330 D Common Stock 2010-03-18 4 S 0 2100 8.8435 D 15230 D Common Stock 2010-03-18 4 S 0 230 9.7539 D 15000 D Common Stock 2010-03-18 4 M 0 40000 1.17 A 55000 D Common Stock 2010-03-18 4 S 0 24500 6.5736 D 30500 D Common Stock 2010-03-18 4 S 0 7500 7.8429 D 23000 D Common Stock 2010-03-18 4 S 0 6800 8.8241 D 16200 D Common Stock 2010-03-18 4 S 0 1200 9.735 D 15000 D Employee Stock Option (right to buy) 1.17 2010-03-18 4 M 0 40000 D 2019-07-15 Common Stock 40000 60000 D This sale was effected by the reporting person pursuant to a pre-planned selling program under Rule 10b5-1 adopted by the reporting person in 2009. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $6.25 to $7.19 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.30 to $8.28 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $8.46 to $9.2256 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $9.735 to $9.88 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $6.25 to $7.23 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.34 to $8.28 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $8.44 to $9.2256 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Fifty percent of the shares of Common Stock subject to this grant vested on March 18, 2010 and the remaining shares will vest and become exercisable upon the Company's consummation of a strategic collaboration relating to Silenor that is approved by the Board of Directors, subject to Reporting Person's continued service to the Company through such vesting date. Not applicable. /s/ Matthew Onaitis, Attorney-in-fact 2010-03-19 -----END PRIVACY-ENHANCED MESSAGE-----